Open Access and Free to Publish in Asian Journal of Health Sciences

Research articles Open Access Logo

Potential Risk Factors and the Effect of Tamsulosin on Postoperative Urinary Retention in Patients Undergoing Anorectal Surgery: A Cross-Sectional Study

Yousef Khani 1
Ali Baradaran Bagheri 1
Mhammadreza Maghsoudi 1
Alireza Shirzadi 1
Mojtaba Ahmadinejad 1, *
  1. Clinical Research Development Unit, Shahid Madani Hospital, Alborz University of Medical Sciences, Karaj, Iran
Correspondence to: Mojtaba Ahmadinejad, Clinical Research Development Unit, Shahid Madani Hospital, Alborz University of Medical Sciences, Karaj, Iran. Email: masterofepidemiology@gmail.com.
Volume & Issue: Vol. 9 No. 1 (2023) | Page No.: ID54 | DOI: 10.15419/ajhs.v9i1.525
Published: 2023-06-30

Online metrics


Statistics from the website

  • HTML Views: 1273
  • PDF Views: 159
  • XML Views: 1

Statistics from Dimensions

Copyright The Author(s) 2017. This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. 

Abstract

Background: Urinary retention is a condition in which patients are unable to completely empty their bladder and is classified into acute and chronic urinary retention. The goal of this study was to determine the incidence of postoperative urinary retention, identify potential factors contributing to its development, and evaluate the preventive role of tamsulosin in preventing this complication in patients undergoing anorectal surgery.

Methods: We reviewed 600 consecutive surgeries performed under spinal or saddle anesthesia for benign anorectal diseases from May 2016 through June 2022 to identify potential risk factors for postoperative urinary retention (POUR). In addition, we retrospectively investigated the preventive effect of tamsulosin on postoperative urinary retention.

Results: The results of multiple regression analysis showed that being over the age of 50 years (OR = 1.659, P = 0.039), having diabetes (OR = 6.592, P < 0.001), benign prostatic hyperplasia (OR = 2.680, P = 0.024), and saddle anesthesia (OR = 1.359, P = 0.511) were risk factors for POUR; however, the results for saddle anesthesia were not statistically significant. On the other hand, male gender (OR = 0.931, P = 0.833), type of anorectal disease (P = 0.531), and the use of tamsulosin (OR = 0.176, P < 0.001) were factors that prevent POUR, but these results were only significant for the use of tamsulosin as a preventive drug. According to the ROC curve, the model fit well and could correctly predict the incidence of urinary retention after anorectal surgery in approximately 83% of cases (P < 0.001).

Conclusion: POUR is a common side effect of anorectal surgeries. Being over the age of 50 years, diabetes, and benign prostatic hyperplasia are risk factors for POUR after anorectal surgeries. Tamsulosin could be used to prevent POUR in candidates for anorectal surgeries.

Introduction

Urinary retention is a condition in which patients are unable to completely empty their bladders. It is classified into acute and chronic urinary retention. Generally, acute urinary retention is characterized by a painful and palpable bladder. This condition often occurs after prolonged anesthesia in extensive surgery, known as postoperative urinary retention (POUR). The incidence of POUR has been reported to range from 2.1 to 80%, varying based on multiple factors such as age, sex, type of anesthesia, surgical techniques, and underlying diseases1, 2, 3, 4, 5, 6. POUR can cause many problems for patients, including embarrassment due to intermittent catheterization, catheter-induced infections, complications from bladder dilatation such as acute kidney injury and detrusor muscle injury, prolonged hospitalization, and the need for additional care after hospital discharge, thereby imposing extra costs on the patient7, 8, 9, 10, 11.

As noted, the type of surgery performed is one of the factors affecting POUR. POUR has been reported in 1 to 52% of cases undergoing anorectal surgeries; however, the causes of POUR in such surgeries are not completely understood7, 12, 13, 14, 15, 16. Various methods have been employed to reduce the risk of urinary retention following anorectal surgeries, including the administration of parasympathomimetic agents, the use of alpha-adrenergic blockers or anxiolytic agents, restriction of perioperative fluid intake, avoidance of excessive anal packing, taking sitz baths, implementing local anesthesia techniques or short-acting anesthetics, and managing surgeries on an outpatient basis13, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27.

Moreover, the role of tamsulosin in preventing POUR has been highlighted in some studies. The mechanism of action of tamsulosin involves relaxing the detrusor muscles and facilitating bladder emptying1, 2, 7, 28, 29, 30, 31, 32, 33. Given the significance of POUR and the limited number of studies conducted on patients undergoing anorectal surgeries in Iran, this study investigates the effect of various potential risk factors associated with urinary retention after these surgeries and evaluates the efficacy of tamsulosin in preventing this complication.

Methods

This study is a retrospective review of data from patients who underwent anorectal surgery at Shahid Madani Hospital, Karaj, from May 2016 to June 2022. Urinary retention was diagnosed when a patient failed to pass urine after the operation despite having a sensation of needing to urinate, adequate fluid intake, and unsuccessful conservative management, such as suprapubic warming, warm sitz baths, and encouragement to get out of bed and walk, which necessitated urinary catheterization. The patients selected for this study had undergone surgery for elective benign anorectal diseases, including hemorrhoids, fissures, and fistulas, from May 2015 to June 2021. Exclusion criteria included age over 70, presence of an active urinary infection, neurologic disorders, urologic diseases, and patients taking tamsulosin for benign prostatic hyperplasia. Patients were divided into two groups: those receiving tamsulosin and a control group. In the tamsulosin group, 0.4 mg of tamsulosin was prescribed 6 hours before and 6 to 12 hours after the operation. In the comparison group, no specific medication was prescribed for urinary excretion. The incidence of postoperative urinary retention (POUR) in the tamsulosin and control groups was considered the main outcome of this study. Factors such as age, sex, type of anorectal disease, diabetes, benign prostatic hyperplasia, and anesthesia techniques were also considered as independent predictors of POUR risk. Differences in the incidence of POUR between the two groups were assessed using the Chi-square test. Univariate analysis and multiple logistic regressions were used to determine the risk factors for POUR. The ROC curve was used to evaluate the goodness of fit of the model. A significance level of 0.05 was considered, and all data analyses were performed using SPSS v.22 software.

Figure 1

Receiver Operator Curve for goodness of fit of multiple logistic regression model.

Table 1

Potential risk factors and tamsulosin effect for postoperative urinary retention in people undergoing anorectal surgery (N=600)

No

Risk Factor

N

Number of Patients with urinary retention

Incidence of urinary retention (%)

Odds Ratio (OR)

P value

Confidence Interval (95%)

1

age

>50

300

66

22

1.51

0.03

1.003-2.297

<50

300

47

15.66

2

sex

Male

300

66

22

1.51

0.03

1.003-2.297

Female

300

47

15.66

3

DM

Present

168

72

42.85

7.152

0.000

4.589-11.147

Absent

432

41

9.49

4

BPH

Present

140

48

34.28

3.171

0.000

2.049-4.906

Absent

460

65

14.13

5

Anesthesia Technique

Saddle

373

40

10.72

0.253

0.000

0.165-0.390

Spinal

227

73

32.15

6

Anorectal Disease

Hemorrhoid

200

37

18.5

0.937

0.973

0.85-1.10

Anal fistula

200

39

19.5

1

0.87-1.13

Anal fissure

200

37

18.5

1.067

0.9-1.16

7

Tamsulosin

Present

300

22

7.33

0.182

0.000

0.110-0.299

Absent

300

91

30.33

Table 2

Potential risk factors and tamsulosin effect for postoperative urinary retention in people undergoing hemorrhoidectomy (N=200)

1

age

>50

104

24

23.07

1.915

0.1

0.912-4.021

<50

96

13

13.54

2

sex

Male

102

24

23.52

2.012

0.07

0.958-4.224

Female

98

13

13.26

3

DM

Present

61

31

50.81

22.906

0.000

8.773-59.807

Absent

139

6

4.31

4

BPH

Present

43

17

39.53

4.479

0.000

2.073-9.679

Absent

157

20

12.73

5

Anesthesia Technique

Saddle

127

10

7.87

0.146

0.000

0.065-0.325

Spinal

73

27

36.98

6

Tamsulosin

Present

100

6

6

0.142

0.000

0.056-0.359

Absent

100

31

31

Table 3

Potential risk factors and tamsulosin effect for postoperative urinary retention in people undergoing fistula surgery fistulectomy (N=200)

No

Risk Factor

Number of Patients with urinary retention

Incidence of urinary retention (%)

Odds Ratio (OR)

P value

Confidence Interval (95%)

1

age

>50

100

26

26

2.351

0.031

1.128-4.901

<50

100

13

13

2

sex

Male

100

23

23

1.568

0.284

0.772-3.187

Female

100

16

16

3

DM

Present

46

17

36.95

3.517

0.001

1.662-7.444

Absent

154

22

14.28

4

BPH

Present

47

18

38.29

3.901

0.001

1.849-8.234

Absent

153

21

13.72

5

Anesthesia Technique

Saddle

126

16

12.69

0.327

0.003

0.157-0.662

Spinal

74

23

31.08

6

Tamsulosin

Present

100

10

10

0.272

0.001

0.124-0.595

Absent

100

29

29

Table 4

Potential risk factors for postoperative urinary retention in people undergoing fistulectomy (N=200)

No

Risk Factor

Number of Patients with urinary retention

Incidence of urinary retention (%)

Odds Ratio (OR)

P value

Confidence Interval (95%)

1

age

>50

96

16

16.66

0.79

0.587

0.385-1.623

<50

104

21

20.19

2

sex

Male

98

19

19.38

1.122

0.856

0.550-2.292

Female

102

18

17.64

3

DM

Present

61

24

39.34

4.207

0.000

2.917-13.552

Absent

139

13

9.35

4

BPH

Present

50

13

26

1.845

0.141

0.856-3.976

Absent

150

24

16

5

Anesthesia Technique

Saddle

120

14

11.66

0.327

0.003

0.156-0.685

Spinal

80

23

28.75

6

Tamsulosin

Present

100

6

6

0.142

0.000

0.056-0.359

Absent

100

31

31

Table 5

Multiple logistic regression model in relation to the incidence of postoperative urinary retention in people who have undergone anorectal surgery

Group Variable

Odds Ratio

95% CI

P value

Age > 50

1.659

1.026-2.684

0.039

Male sex

0.931

0.481-1.803

0.833

DM

6.592

3.229-13.461

0.000

BPH

2.680

1.137-6.321

0.024

Anorectal disease

Hemorrhoid

Ref

Ref

0.531

Fistulectomy

0.716

0.396-1.294

0.269

Fistulectomy

0.887

0.493-1.597

0690

Saddle Anesthesia Technique

1.359

0.544-3.395

0.511

Tamsulosin use

0.176

0.102-0.304

0.000

Results

The results of the data analysis are presented in Table 1, Table 2, Table 3, Table 4, Table 5 and Figure 1. The results of the univariate analysis of the patients who underwent anorectal surgery are presented in Table 1. Age above and under 50 years, gender, diabetes, benign prostatic hyperplasia, type of anorectal surgery, anesthesia technique, and tamsulosin administration were considered as potential predictors of POUR. The overall prevalence of POUR in this study was 18.83%. Age over 50 years and male gender were identified as risk factors for POUR (OR = 1.51, P = 0.03). Diabetes (OR = 7.152, P < 0.001) and benign prostatic hyperplasia (OR = 3.171, P < 0.001) were other risk factors for POUR in this study. The prevalence of POUR was 18.5% in patients who underwent surgery for hemorrhoids and anal fissures, and 19.5% in cases who underwent surgery for anal fistulas; however, these differences were not statistically significant (P = 0.973). Also, according to the results, saddle anesthesia (OR = 0.253, P < 0.001) and the administration of tamsulosin (OR = 0.182, P < 0.001) could be considered as preventive factors for POUR.

Table 2 to Table 4 present the results of univariate analysis for patients who underwent surgery for hemorrhoids, anal fistulas, and fissures. According to Table 2, age over 50 years (OR = 1.915, P = 0.1) and male gender (OR = 2.012, P = 0.07) were risk factors for POUR; however, these results were not statistically significant. Additionally, the role of diabetes (OR = 22.906, P < 0.001) and benign prostatic hyperplasia (OR = 4.479, P < 0.001) as risk factors, as well as saddle anesthesia (OR = 0.146, P < 0.001) and the administration of tamsulosin (OR = 0.142, P < 0.001) (Table 1), as effective factors in preventing POUR, was also confirmed in people who underwent surgery to remove hemorrhoids.

The results of Table 3 show that in cases who underwent surgery to treat fistulas, the age over 50 years (OR = 2.351, P = 0.031) and male gender (OR = 1.568, P = 0.284) were risk factors for POUR; however, these results were not statistically significant in terms of gender. Similarly (Table 1), diabetes (OR = 3.517, P < 0.001) and benign prostatic hyperplasia (OR = 3.901, P < 0.001) were risk factors, and saddle anesthesia (OR = 0.327, P = 0.003) and the use of tamsulosin (OR = 0.272, P < 0.001) were effective in preventing POUR in patients who underwent surgery for anal fistulas.

Table 4 indicates the results of patients who underwent anal fissure surgery. The age over 50 years (OR = 0.79, P = 0.587) was a preventive factor, and male gender (OR = 1.122, P = 0.856) and benign prostatic hyperplasia (OR = 1.845, P = 0.141) were risk factors for POUR, which were not statistically significant. However, in general (Table 1 ), diabetes (OR = 4.207, P < 0.001) was a risk factor for POUR and saddle anesthesia (OR = 0.327, P = 0.003) and the use of tamsulosin (OR = 0.142, P < 0.001) were factors associated with preventing POUR.

The results of multiple regression analysis are presented in Table 5. The results showed that age over 50 years (OR = 1.659, P = 0.039), diabetes (OR = 6.592, P < 0.001), benign prostatic hyperplasia (OR = 2.680, P = 0.024), and saddle anesthesia (OR = 1.359, P = 0.511) were risk factors for POUR; however, this result was not statistically significant in terms of saddle anesthesia. On the other hand, based on the results, male gender (OR = 0.931, P = 0.833), type of anorectal disease (P = 0.531), and the use of tamsulosin (OR = 0.176, P < 0.001) are factors that prevent POUR, but this issue was only significant in terms of using tamsulosin. The difference between the results of multiple logistic regression and univariate analysis in terms of male gender and saddle anesthesia indicates that their results were distorted by other variables, which could be fixed after being included in the multiple logistic regression model.

Figure 1 shows the ROC curve for the results of the regression model presented in Table 5. According to the results, the good fit of the model was appropriate and the model can correctly predict the incidence of urinary retention after anorectal surgery in approximately 83% of cases (P < 0.001).

Discussion

POUR is one of the most common complications after surgeries2, 10. Urinary retention after anorectal surgeries is also relatively common, with incidence rates reported between 1% to 52%. The wide variation is due to differences in the definition of POUR, differences in inclusion and exclusion criteria, and its multifactorial nature, including variations in age and gender of the patients, the type of anorectal surgeries, and the type of anesthesia. Although the cause of urinary retention after anorectal surgery is not completely clear, some studies have claimed that it could be related to decreased bladder contraction ability or bladder outlet obstruction13, 23, 34. POUR can lead to several problems for patients, including urinary tract infections due to intermittent catheterization, discomfort and embarrassment due to catheterization, and increased treatment costs due to prolonged hospitalization, treatment of secondary infections, and follow-up2, 10. Therefore, the prevention of this complication is of great importance. Several factors, such as age, sex, diabetes, benign prostatic hyperplasia, the type of anorectal surgery, and the type of anesthesia could be responsible for the incidence of POUR. Numerous studies have also suggested the role of tamsulosin in the prevention of this complication1, 2, 7, 28, 29, 30, 31, 32, 33. In our study, the incidence of POUR was 18.83%, which was higher than that in similar studies13, 35. This observation could be due to the higher prevalence of diabetes and benign prostatic hyperplasia in our study, both risk factors for POUR, and the results were also statistically significant. Typically, the incidence of POUR is higher in men, which may be related to an increased rate of prostatomegaly in men with age; however, some studies have reported a higher prevalence in women10, 13, 30, 35, 36, 37, 38. In our study, univariate analysis showed that POUR is more common in men. However, in multiple logistic regression, although its incidence was higher in men, it was not statistically significant, indicating that in univariate analysis, the role of gender in POUR was distorted; therefore, it is recommended to consider this in future studies. The age of patients is another factor that can affect the incidence of POUR, which has been studied previously in various studies. The risk of POUR increases with age, which may be due to impaired neural pathways involved in micturition. Our results showed that the age of over 50 years was a risk factor for POUR, which is consistent with some studies and contradicts others7, 13, 31, 32, 39, 40, 41. In studies where age was not a risk factor for POUR, the sample size was smaller than in our study, while in another study13, where similar to our study from the perspective of the sample size, the age of over 50 years was a risk factor for POUR. Therefore, it seems that the small sample size is the reason for no significant effect of age on POUR in some studies. In our study, diabetes was an important risk factor for POUR, which is consistent with other studies13, 42. Thus, it is recommended to monitor diabetic patients after surgery for retention of urine. Benign prostatic hyperplasia in men can lead to secondary bladder outlet obstruction. Benign prostatic hyperplasia is one of the first and most common causes of bladder outlet obstruction in men and its prevalence increases with age. Treatment failure in benign prostatic hyperplasia can lead to bladder detrusor muscle damage; thus, this condition has been mentioned as one of the risk factors for POUR in various studies19, 43, 44, 45 and is also in line with our results. Some surgeries, including anorectal surgery, are associated with a higher risk of POUR11, 17, 39. On the other hand, Toyonaga 13 showed that in cases who underwent anorectal surgeries, the risk of POUR was higher in those who underwent hemorrhoid, fissure, and fistula surgeries, but in our study, the results showed no significant difference. In terms of surgical and anesthetic techniques, studies have shown different results, so that in some studies, general anesthesia was associated with a higher risk of POUR than local anesthesia, and vice versa3, 40, 46, 47. In our study, only spinal and saddle anesthesia were implemented for surgery. According to the results of univariate analysis, saddle anesthesia was associated with a lower risk of POUR than local anesthesia, while based on multiple regression analysis, the opposite results were obtained, which were not statistically significant, indicating distortion of the results of univariate analysis. The α-adrenergic receptors (α-ARs) located dominantly in the outlet of the bladder and urethra are responsible for the internal sphincter tone, and antagonists of these receptors, including tamsulosin, can reduce the incidence of POUR after colorectal and urological surgeries in men. Tamsulosin mainly acts by alleviating detrusor-sphincter dyssynergia and facilitates bladder emptying, which was confirmed by our results28, 29, 30, 31, 32, 33, 37, 48, 49, 50, 51.

Conclusions

POUR is common in anorectal surgeries. Being over 50 years old, having diabetes, and suffering from benign prostatic hyperplasia are risk factors for POUR after anorectal surgery. Tamsulosin could be used to prevent POUR in candidates undergoing anorectal surgeries.

Abbreviations

POUR - Postoperative Urinary Retention, OR - Odds Ratio, ROC - Receiver Operating Characteristic, SPSS - Statistical Package for the Social Sciences

Acknowledgments

None.

Author’s contributions

All authors significantly contributed to this work, read and approved the final manuscript.

Funding

The financial resources of this research were provided by Shahid Madani Hospital.

Availability of data and materials

Data and materials used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Ethics approval and consent to participate

This study was conducted using the data of patients' files and there was no specific ethical problem that required informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

  1. C.M. Papageorge, B. Howington, G. Leverson, G.D. Kennedy, E.H. Carchman. Preoperative Tamsulosin to Prevent Postoperative Urinary Retention: A Randomized Controlled Trial. The Journal of Surgical Research 2021; 262: 130-9.
  2. P. Sirisreetreerux, R. Wattanayingcharoenchai, S. Rattanasiri, O. Pattanaprateep, P. Numthavaj, A. Thakkinstian. Medical and non-medical interventions for post-operative urinary retention prevention: network meta-analysis and risk-benefit analysis. Therapeutic Advances in Urology 2021; 13:
  3. B.S. Hansen, E. S∅reide, A.M. Warland, O.B. Nilsen. Risk factors of post-operative urinary retention in hospitalised patients. Acta Anaesthesiologica Scandinavica 2011; 55(5): 545-8.
  4. A.K. Wu, A.D. Auerbach, D.S. Aaronson. National incidence and outcomes of postoperative urinary retention in the Surgical Care Improvement Project. American Journal of Surgery 2012; 204(2): 167-71.
  5. Y.H. Cha, Y.K. Lee, S.H. Won, J.W. Park, Y.C. Ha, K.H. Koo. Urinary retention after total joint arthroplasty of hip and knee: systematic review. Journal of Orthopaedic Surgery (Hong Kong) 2020; 28(1):
  6. C. Chong, H.S. Kim, D.H. Suh, B.C. Jee. Risk factors for urinary retention after vaginal hysterectomy for pelvic organ prolapse. Obstetrics {&amp;}amp; Gynecology Science 2016; 59(2): 137-43.
  7. J. Jackson, P. Davies, N. Leggett, M.D. Nugawela, L.J. Scott, V. Leach. Systematic review of interventions for the prevention and treatment of postoperative urinary retention. BJS Open 2018; 3(1): 11-23.
  8. B.S. Niël-Weise, P.J. van den Broek. Urinary catheter policies for short‐term bladder drainage in adults. Cochrane Database of Systematic Reviews 2005; 2005(3):
  9. V.K. Alamanda, B.D. Springer. Perioperative and modifiable risk factors for periprosthetic joint infections (PJI) and recommended guidelines. Current Reviews in Musculoskeletal Medicine 2018; 11(3): 325-31.
  10. G. Baldini, H. Bagry, A. Aprikian, F. Carli, D.S. Warner, M.A. Warner. Postoperative urinary retention: anesthetic and perioperative considerations. Anesthesiology 2009; 110(5): 1139-57.
  11. D.J. Pavlin, S.E. Rapp, N.L. Polissar, J.A. Malmgren, M. Koerschgen, H. Keyes. Factors affecting discharge time in adult outpatients. Anesthesia and Analgesia 1998; 87(4): 816-26.
  12. P. Kandadai, J. Saini, D. Patterson, K. O'Dell, M. Flynn. Urinary retention after hysterectomy and postoperative analgesic use. Female Pelvic Medicine {&amp;}amp; Reconstructive Surgery 2015; 21(5): 257-62.
  13. T. Toyonaga, M. Matsushima, N. Sogawa, S.F. Jiang, N. Matsumura, Y. Shimojima. Postoperative urinary retention after surgery for benign anorectal disease: potential risk factors and strategy for prevention. International Journal of Colorectal Disease 2006; 21(7): 676-82.
  14. L. Gottesman, J.W. Milsom, W.P. Mazier. The use of anxiolytic and parasympathomimetic agents in the treatment of postoperative urinary retention following anorectal surgery. A prospective, randomized, double-blind study. Diseases of the Colon and Rectum 1989; 32(10): 867-70.
  15. F.J. Bowers, R. Hartmann, K.S. Khanduja, T.G. Hardy, P.S. Aguilar, W.R. Stewart. Urecholine prophylaxis for urinary retention in anorectal surgery. Diseases of the Colon and Rectum 1987; 30(1): 41-2.
  16. M.S. Eftaiha, A.L. Amshel, I.L. Shonberg. Comparison of two agents in prevention of urinary retention after benign anorectal surgery. Diseases of the Colon and Rectum 1980; 23(7): 470-2.
  17. J.G. Petros, T.M. Bradley. Factors influencing postoperative urinary retention in patients undergoing surgery for benign anorectal disease. American Journal of Surgery 1990; 159(4): 374-6.
  18. M. De la Garza, T.C. Counihan. Complications of hemorrhoid surgery. Seminars in Colon and Rectal Surgery 2013; :
  19. U. Kowalik, M.K. Plante. Urinary retention in surgical patients. The Surgical Clinics of North America 2016; 96(3): 453-67.
  20. P.A. Cataldo, A.J. Senagore. Does alpha sympathetic blockade prevent urinary retention following anorectal surgery?. Diseases of the Colon and Rectum 1991; 34(12): 1113-6.
  21. H.R. Bailey, J.A. Ferguson. Prevention of urinary retention by fluid restriction following anorectal operations. Diseases of the Colon and Rectum 1976; 19(3): 250-2.
  22. M.L. Prasad, H. Abcarian. Urinary retention following operations for benign anorectal diseases. Diseases of the Colon and Rectum 1978; 21(7): 490-2.
  23. R. Pompeius. Detrusor inhibition induced from anal region in man. Acta Chirurgica Scandinavica. Supplementum 1966; 361: 1-54.
  24. A. Shafik. Role of warm water bath in inducing micturition in postoperative urinary retention after anorectal operations. Urologia Internationalis 1993; 50(4): 213-7.
  25. M. Fleischer, C.P. Marini, R. Statman, J. Capella, K. Shevde. Local anesthesia is superior to spinal anesthesia for anorectal surgical procedures. The American Surgeon 1994; 60(11): 812-5.
  26. H. Morisaki, J. Masuda, K. Fukushima, Y. Iwao, K. Suzuki, M. Matsushima. Wound infiltration with lidocaine prolongs postoperative analgesia after haemorrhoidectomy with spinal anaesthesia. Canadian Journal of Anaesthesia 1996; 43(9): 914-8.
  27. S.D. Hoff, H.R. Bailey, D.R. Butts, E. Max, K.W. Smith, L.F. Zamora. Ambulatory surgical hemorrhoidectomy - solution to postoperative urinary retention?. Diseases of the Colon and Rectum 1994; 37(12): 1242-4.
  28. M. Mohammadi-Fallah, S. Hamedanchi, A. Tayyebi-Azar. Preventive effect of tamsulosin on postoperative urinary retention. Korean Journal of Urology 2012; 53(6): 419-23.
  29. V. Poylin, T. Curran, T. Cataldo, D. Nagle. Perioperative use of tamsulosin significantly decreases rates of urinary retention in men undergoing pelvic surgery. International Journal of Colorectal Disease 2015; 30(9): 1223-8.
  30. A.H. Madani, H.B. Aval, G. Mokhtari, H. Nasseh, S. Esmaeili, M. Shakiba. Effectiveness of tamsulosin in prevention of post-operative urinary retention: a randomized double-blind placebo-controlled study. International Braz J Urol 2014; 40(1): 30-6.
  31. A. Basheer, M. Alsaidi, L. Schultz, M. Chedid, M. Abdulhak, D. Seyfried. Preventive effect of tamsulosin on postoperative urinary retention in neurosurgical patients. Surgical Neurology International 2017; 8(1): 75.
  32. M. Shokrpour, E. Shakiba, A. Sirous, A. Kamali. Evaluation the efficacy of prophylactic tamsulosin in preventing acute urinary retention and other obstructive urinary symptoms following colporrhaphy surgery. Journal of Family Medicine and Primary Care 2019; 8(2): 722-7.
  33. G.C. Chapman, D. Sheyn, A. Petrikovets, S.T. Mahajan, S. El-Nashar, R. Pollard. Tamsulosin to prevent postoperative urinary retention after female pelvic reconstructive surgery. Female Pelvic Medicine & Reconstructive Surgery 2020; 26(11): 682-7.
  34. J.G. Barone, K.B. Cummings. Etiology of acute urinary retention following benign anorectal surgery. The American Surgeon 1994; 60(3): 210-1.
  35. S. Zaheer, W.T. Reilly, J.H. Pemberton, D. Ilstrup. Urinary retention after operations for benign anorectal diseases. Diseases of the Colon and Rectum 1998; 41(6): 696-704.
  36. H. Keita, E. Diouf, F. Tubach, T. Brouwer, S. Dahmani, J. Mantz. Predictive factors of early postoperative urinary retention in the postanesthesia care unit. Anesthesia and Analgesia 2005; 101(2): 592-6.
  37. T. Tammela, M. Kontturi, O. Lukkarinen. Postoperative urinary retention. I. Incidence and predisposing factors. Scandinavian Journal of Urology and Nephrology 1986; 20(3): 197-201.
  38. P.S. Myles, J.O. Hunt, J.T. Moloney. Postoperative `minor' complications. Comparison between men and women. Anaesthesia 1997; 52(4): 300-6.
  39. D.M. Darrah, T.L. Griebling, J.H. Silverstein. Postoperative urinary retention. Anesthesiology Clinics 2009; 27(3): 465-84.
  40. L. Lamonerie, E. Marret, A. Deleuze, N. Lembert, M. Dupont, F. Bonnet. Prevalence of postoperative bladder distension and urinary retention detected by ultrasound measurement. British Journal of Anaesthesia 2004; 92(4): 544-6.
  41. S.E. Elsamra, P. Ellsworth. Effects of analgesic and anesthetic medications on lower urinary tract function. Urologic Nursing 2012; 32(2): 60-7.
  42. K.H. Sung, K.M. Lee, C.Y. Chung, S.-S. Kwon, S.Y. Lee, Y.S. Ban. What are the risk factors associated with urinary retention after orthopaedic surgery?. BioMed research international 2015; 2015: 613216.
  43. D. Altschul, A. Kobets, J. Nakhla, A. Jada, R. Nasser, M.D. Kinon. Postoperative urinary retention in patients undergoing elective spinal surgery. Journal of Neurosurgery. Spine 2017; 26(2): 229-34.
  44. K.M. Verhamme, J.P. Dieleman, M.A. van Wijk, J.L. Bosch, B.H. Stricker, M.C. Sturkenboom. Low incidence of acute urinary retention in the general male population: the triumph project. European Urology 2005; 47(4): 494-8.
  45. S.E. Mason, A.J. Scott, E. Mayer, S. Purkayastha. Patient-related risk factors for urinary retention following ambulatory general surgery: a systematic review and meta-analysis. American Journal of Surgery 2016; 211(6): 1126-34.
  46. E.T. Kamphuis, T.I. Ionescu, P.W. Kuipers, J. de Gier, G.E. van Venrooij, T.A. Boon. Recovery of storage and emptying functions of the urinary bladder after spinal anesthesia with lidocaine and with bupivacaine in men. Anesthesiology 1998; 88(2): 310-6.
  47. P. Jensen, T. Mikkelsen, H. Kehlet. Postherniorrhaphy urinary retention\textemdasheffect of local, regional, and general anesthesia: a review. Regional Anesthesia and Pain Medicine 2002; 27(6): 612-7.
  48. A. Ghuman, S.W. de Jonge, S.D. Dryden, T. Feeney, D.H. Buitrago, P.T. Phang. Prophylactic use of alpha-1 adrenergic blocking agents for prevention of postoperative urinary retention: A review &amp; meta-analysis of randomized clinical trials. American Journal of Surgery 2018; 215(5): 973-9.
  49. A. Akkoc, C. Aydin, R. Topaktas, M. Kartalmis, S. Altin, K. Isen. Prophylactic effects of alpha-blockers, Tamsulosin and Alfuzosin, on postoperative urinary retention in male patients undergoing urologic surgery under spinal anaesthesia. International Braz J Urol 2016; 42(3): 578-84.
  50. C. Clancy, J.C. Coffey, M.G. O'Riordain, J.P. Burke. A meta-analysis of the efficacy of prophylactic alpha-blockade for the prevention of urinary retention following primary unilateral inguinal hernia repair. American Journal of Surgery 2018; 216(2): 337-41.
  51. N. Bazzazi, H.M. Bahar, H.K. Asadi, S. Akbarzadeh, D.F. Fouladi. Prophylactic tamsulosin in cataract surgery under general anesthesia for preventing urinary retention: a randomized clinical trial. International Eye Science. 2014; 14(1): 1-3.

Comments